New drug shows promise for alcohol hepatitis in small trial

NCT ID NCT06685692

First seen Jan 07, 2026 · Last updated May 22, 2026 · Updated 17 times

Summary

This study tested a new medicine called ADX-629 in 4 adults with moderate alcohol-related hepatitis. The goal was to see if the drug is safe and helps control liver inflammation. Participants agreed to stop drinking alcohol during the trial. The study is complete, but results are not yet widely available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL HEPATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Bon Secours Liver Institute of Newport News

    Richmond, Virginia, 23221, United States

  • Florida Health Sciences Center/Tampa General Hospital/USF

    Tampa, Florida, 33606, United States

  • Methodist Specialty and Transplant Hospital

    San Antonio, Texas, 78229, United States

  • Synergry Healthcare

    Bradenton, Florida, 34209, United States

  • The Liver Institute at Methodist Dallas Medical Center

    Dallas, Texas, 75203, United States

  • UDL Clinical Research, LLC

    Houston, Texas, 77057, United States

Conditions

Explore the condition pages connected to this study.